To study the effect of monthly 0.3-mg intravitreal ranibizumab injections on intraretinal hard exudates (HEs) and correlate the effect with macular thickness in eyes with diabetic macular edema (DME). Design: Controlled, randomized trial. Methods: Twenty-four eyes of 24 subjects with DME were included in this istitutional review board approved, prospective longitudinal study.
Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema / S. Srinivas, A. Verma, M.G. Nittala, A.R. Alagorie, M. Nassisi, J. Gasperini, S.R. Sadda. - In: AMERICAN JOURNAL OF OPHTHALMOLOGY. - ISSN 1879-1891. - 211(2020 Mar), pp. 183-190.
Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema
M. Nassisi;
2020
Abstract
To study the effect of monthly 0.3-mg intravitreal ranibizumab injections on intraretinal hard exudates (HEs) and correlate the effect with macular thickness in eyes with diabetic macular edema (DME). Design: Controlled, randomized trial. Methods: Twenty-four eyes of 24 subjects with DME were included in this istitutional review board approved, prospective longitudinal study.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
